Duncan Cole
Senior Lecturer
Medicine
Cardiff University School of Medicine
United Kingdom
Biography
I trained in medicine in Cardiff and South Wales, and obtained the MRCP in 2002, following which I undertook a PhD whilst on an MRC Clinical Training Fellowship with Prof Paul Morgan. I went on to train in Chemical Pathology and Metabolic Medicine, gaining the FRCPath in 2010 and sub-specialising in inherited metabolic disease. During this time I took an increasing role in teaching and curriculum development within the Department and medical school, and was appointed as a Clinical Senior Lecturer in 2011 on a teaching and scholarship track.
Research Interest
I am a Clinical Senior Lecturer in the Centre for Medical Education in the School of Medicine, and an Honorary Consultant in Medical Biochemistry and Metabolic Medicine. I have interests in curriculum development, clinical reasoning and clinical decision making, and in technology-enhanced learning. I have responsibilities across several modules in the medical curriculum, and am an active member of the Phase 2 Working Group. My work in these areas was recognised when I won the Rising Star award at the national BMA Cymru Wales Clinical Teacher of the Year awards in 2015. My clinical interests are in adult inherited metabolic disease (IMD), where I am the clinical lead for the All Wales IMD service, and also in medical biochemistry, where I am consultant lead for several specialist services. The All Wales IMD service is nationally comissioned and cares for both children and adults. We provide services for people with lysosomal storage disease and are the only in centre in Wales that provides enzyme replacement therapy. We have recently been commissioned to develop our services for people with non-lysosomal storage disease, and to improve access to care for those in north Wales. Our unit is also a centre for the National Acute Porphyria Service, commissioned through NHS England. We host both clinical and laboratory services, including the Wales Newborn Screening Laboratory, and have a growing research base.
Publications
-
Donev, R.et al. 2006. p53 regulates cellular resistance to complement lysis through enhanced expression of CD59. Cancer Research 66(4), pp. 2451-8. (10.1158/0008-5472.CAN-05-3191)
-
Sivasankar, B.et al. 2007. CD59a deficient mice display reduced B cell activity and antibody production in response to T-dependent antigens. Molecular Immunology 44(11), pp. 2978-2987. (10.1016/j.molimm.2006.12.025)